CAS 4111-54-0|Lithium diisopropylamide
| Common Name | Lithium diisopropylamide | ||
|---|---|---|---|
| CAS Number | 4111-54-0 | Molecular Weight | 107.123 |
| Density | 0.864 g/mL at 25 °C(lit.) | Boiling Point | 65 °C |
| Molecular Formula | C6H14LiN | Melting Point | 38-42ºC |
| MSDS | ChineseUSA | Flash Point | 91 °F |
| Symbol | GHS02, GHS05, GHS07, GHS08, GHS09 | Signal Word | Danger |
Names
| Name | lithium,di(propan-2-yl)azanide |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 0.864 g/mL at 25 °C(lit.) |
|---|---|
| Boiling Point | 65 °C |
| Melting Point | 38-42ºC |
| Molecular Formula | C6H14LiN |
| Molecular Weight | 107.123 |
| Flash Point | 91 °F |
| Exact Mass | 107.128632 |
| PSA | 3.24000 |
| LogP | 1.56950 |
| Appearance of Characters | liquid | brown |
| Vapour density | >1 (vs air) |
| InChIKey | ZCSHNCUQKCANBX-UHFFFAOYSA-N |
| SMILES | CC(C)[N-]C(C)C.[Li+] |
| Storage condition | 2-8°C |
| Water Solubility | decomposes |
Safety Information
| Symbol | GHS02, GHS05, GHS07, GHS08, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H250-H302-H304-H314-H335-H336-H351-H361f-H373-H411 |
| Supplemental HS | May form explosive peroxides. |
| Precautionary Statements | P210-P231-P280-P305 + P351 + P338-P370 + P378-P422 |
| Hazard Codes | F:Flammable;C:Corrosive;N:Dangerousfortheenvironment; |
| Risk Phrases | R11;R14;R15;R19;R35;R51/53;R65;R67 |
| Safety Phrases | S26-S36/37/39-S43-S45-S60-S61-S62-S8-S16-S23-S33-S27 |
| RIDADR | UN 3399 4.3/PG 2 |
| WGK Germany | 3 |
| Packaging Group | I |
| Hazard Class | 4.2 |
| HS Code | 2924199090 |
Customs
| HS Code | 2924199090 |
|---|---|
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Articles94
More Articles| Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression. PLoS ONE 10 , e0120295, (2015) Recent genome wide association studies have linked tribbles pseudokinase 1 (TRIB1) to the risk of coronary artery disease (CAD). Based on the observations that increased expression of TRIB1 reduces se... | |
| Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia. Blood Cells Mol. Dis. 54(2) , 139-43, (2015) Vascular endothelial growth factor type A (VEGFA) is a key regulator of angiogenesis and vascular permeability. Chronic lymphocytic leukemia (CLL) cells are able to secrete VEGFA and express VEGFA rec... | |
| Pendant allyl crosslinking as a tunable shape memory actuator for vascular applications. Acta Biomater. 24 , 53-63, (2015) Thermo-responsive shape memory polymers (SMPs) can be programmed to fit into small-bore incisions and recover their functional shape upon deployment in the body. This property is of significant intere... |
Synonyms
| 2-Propanamine, N-(1-methylethyl)-, lithium salt (1:1) |
| LDA |
| Lithium diisopropylamide |
| lithium diisopropylamine |
| Lithium diisopropylamide solution |
| EINECS 223-893-0 |
| UNII-OL028KIW1I |
| lithium N,N-diisopropylamide |
| Lithium diisopropylamide,LDA |
| Lithium diisopropylazanide |
| Lithium Diisopropylamide (LDA) |
| lithiumdiisopropylamide |
| lithium diisopropyl amide |
| MFCD00064449 |
| lithium di(propan-2-yl)azanide |
